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Abstract The mustard trypsin inhibitor MTI2 was expressed as
secretory protein in the yeast Pichia pastoris. In order to
evaluate the influence of the C-terminal amino acids of the
precursor form on the inhibitor activity, the C-terminal precursor
and the mature protein were both expressed. A third His-tagged
construct was also designed to compare alternative purification
procedures. Proteins were efficiently expressed at levels of 40^
160 mg/l in shake flasks. Equilibrium dissociation constants
demonstrated that the mature protein was a stronger inhibitor of
bovine L-trypsin compared to the precursor and His-tagged
forms (0.01 nM vs. 0.58 nM and 0.71 nM, respectively). The
recombinant proteins were active inhibitors of Spodoptera exigua
gut proteases.
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1. Introduction
Protease inhibitors of plants have been classi¢ed according
to the proteolytic enzymes upon which they act (serine, cys-
teine, aspartic and metallo-proteases). Inhibitors of serine pro-
teases are the most extensively characterized and they are
currently subdivided into at least eight families of structurally
di¡erent molecules [1].
In seeds of the Crucifera mustard (Sinapis alba), two di¡er-
ent trypsin inhibitors (MTI and MTI2) have been identi¢ed
[2,3]. MTI shows some characteristics in common with the
soybean trypsin inhibitor of the Kunitz type and has a re-
ported inhibition constant of 2.2 nM for trypsin. MTI2 was
the ¢rst protease inhibitor which was sequenced from Cruci-
ferae [3]. It is a polypeptide of 63 amino acids, rich in cysteine
and glycine residues, showing no structural homology with
other known families of plant serine protease inhibitors. Sim-
ilar protease inhibitors have been puri¢ed from rapeseed
(Brassica napus) seeds [4,5], supporting the hypothesis that
they represent a new family of serine protease inhibitors,
which could be characteristic of Cruciferae. MTI2 is a potent,
heat-stable inhibitor of trypsin with a reported Ki of 0.16 nM
[3].
The gene encoding the MTI2 protein is discontinuous with
a single intron located upstream of the region encoding the
mature protein [6]. The MTI2 gene encodes a 99 amino acid
precursor having 30 and six amino acids at the amino- and
carboxy-termini respectively, which are not present in the ma-
ture protein. The gene is expressed in seeds toward the end of
maturation and in leaves only after wounding.
The 30 amino acids at the N-terminus of the precursor
polypeptide contain a cluster of hydrophobic residues £anked
by charged amino acids which most likely represents the sig-
nal peptide for secretion into the endoplasmic reticulum [7].
The role of the C-terminal portion remains unknown. In this
paper we investigate the possibility that the C-terminal pep-
tide keeps the inhibitor inactive.
The possibility that mature MTI2 could constitute a defen-
sive molecule in leaves is suggested by the wound inducibility
of the gene, and this has been con¢rmed by expressing the
MTI2 gene in tobacco and Arabidopsis thaliana plants under
the constitutive CaMV35S promoter. When the MTI2 gene
was expressed at high levels in transgenic tobacco plants a
decrease in leaf surface eaten by Spodoptera littoralis larvae
together with a reduction in mean larval weight and increased
mortality was observed [8].
A broader analysis of MTI2 antimetabolic activity on dif-
ferent insects, of the role of the C-terminal peptide, and of the
protein structure has been impeded so far by the small
amounts of MTI2 that can be puri¢ed from mustard seeds.
In order to overcome this problem, we have expressed the
MTI2 mature protein and its C-terminal precursor in the
methylotrophic yeast Pichia pastoris.
2. Materials and methods
2.1. Oligonucleotides
The following primers (Life Technologies) were used for PCR am-
pli¢cations. Triplets correspond to amino acid codons; restriction
sites are underlined (see Fig. 1 for primer locations).
1. 5P-ATG GCC ATG GCA AAA AAA TCA GTT TCT TCG TTC
ACC C-3P.
2. 5P-GGGGG GAA TTC CAT CAC CAT CAC CAT CAC GAT
AGC GAG TGC CTG AAA GAA TAC GG-3P, restriction site
EcoRI.
3. 5P-AAAAAAAAA CTC GAG AAA AGA GAG GCT GAA GCT
GAT AGC GAG TGC CTG AAA GAA TAC-3P, restriction site
XhoI. This primer fuses the MTI2 mature protein immediately
downstream of the K-factor secretion signal sequence and down-
stream of the Glu^Ala repeat which is removed by the yeast di-
peptidyl aminopeptidase STE 13 (see Pichia Expression Kit man-
ual).
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4. 5P-GGGGGGAAT TCA CTG ATC AAA AGG GCT GTC GTT
GCA GTA G-3P, restriction site EcoRI.
5. 5P-AAAAAAAAAGCGGCCGC CTA AAT GCC ACC TCT
TAG AAT CTG-3P, restriction site NotI.
6. 5P-GGCACCTGCAGGAAC TCA AAT GCC-3P, restriction site
PstI. The ¢rst 15 nucleotides of the primer derive from the 3P
£anking region of the MTI2 gene [3]. A single nucleotide mutation
allows the generation of a PstI restriction site.
2.2. Synthesis of the MTI2 cDNA and subcloning into pPIC9
Poly(A) mRNA from immature mustard seeds was prepared as
described [6]. RT-PCR was performed using oligonucleotides 1 and 6
as described in [6] with the only di¡erence that ampli¢cation was run
for 30 cycles of 60 s at 94‡C, 60 s at 70‡C and 60 s at 72‡C. The
resulting cDNA was cloned into pUC19. Using this template PCR
ampli¢cations were run with three di¡erent primer combinations:
2 and 4, 3 and 5, 3 and 4. PCR ampli¢cations were run for 30 cycles
of 60 s at 94‡C, 60 s at 65‡C (for the primer combinations 2/4 and 3/4)
or 60‡C (for the primer combination 3/5) and 60 s at 72‡C. All the
reactions were performed using standard conditions: in a ¢nal volume
of 100 Wl, 50 pmol of each primer was added in the presence of 1.5
mM MgCl2, 0.5 mM of each dNTP and 2.5 U Taq polymerase (Prom-
ega).
Ampli¢ed fragments were digested with the appropriate restriction
enzymes and cloned into the pPIC9 vector (Invitrogen).
2.3. Transformation of P. pastoris
About 15 Wg of recombinant pPIC9 constructs, previously linear-
ized with SalI, was electroporated into P. pastoris strain GS115 (his4)
cells (Invitrogen) [9] using a Bio-Rad Gene Pulser and plated on MD
agar plates without histidine (1.34% YNB (yeast nitrogen base with
ammonium sulfate and without amino acids, Difco), 400 Wg/l biotin,
1% D-glucose, 1.5% agar). Single colonies were inoculated in 500 Wl of
BMG medium (100 mM potassium phosphate pH 6.0, 1.34% YNB,
450 Wg/l biotin, 1% glycerol). Cultures were grown overnight at 30‡C
on a plate agitator at 250 rpm. Cells were pelleted and resuspended to
OD600 = 1.0 in 500 Wl BMM medium (100 mM potassium phosphate,
pH 6.0, 1.34% YNB, 450 Wg/l biotin, 0.5% methanol). Cultures were
incubated in the same conditions as above and supplemented daily
with 50 Wl of BMM medium containing 5% methanol for 96 h.
2.4. Selection of high expressors
Trypsin inhibitor activity in miniculture supernatants and in frac-
tions eluted from chromatography columns was evaluated by radial
di¡usion assay as described in [10]. This method is quantitative over a
large concentration range and allows screening of many samples with
little e¡ort.
For a quantitative evaluation of inhibitor activity ¢rst a reference
curve was determined by relating the concentration of active recombi-
nant proteins, evaluated by the benzoyl DL-arginine p-nitroanilide
(BApNA) assay, with the diameters of the colorless halo [10].
2.5. Fermentation of His-MTI2, Cpre-MTI2 and MTI2 P. pastoris
strains
Positive recombinant clones were inoculated in 100 ml of BMGY
medium (1% yeast extract, 2% peptone in BMG medium) in a 250 ml
£ask for 24 h at 30‡C in a shaking incubator at 250 rpm. An aliquot
of the culture was diluted to OD600 = 1.0 in a ¢nal volume of 500 ml
of BMMY (1% yeast extract, 2% peptone in BMM medium) medium.
The diluted culture was incubated in a 2 l £ask under the same con-
ditions as above for 96 h with a daily supplement of 50 ml of BMMY
bu¡er containing 5% methanol. After induction the culture was stored
at 4‡C.
2.6. Puri¢cation of secreted His-MTI2 protein
Cells from a His-MTI2 culture induced with methanol for 96 h were
pelleted by centrifugation at 1500Ug for 10 min at 4‡C. The super-
natant was ¢ltered using a 0.22 Wm ¢lter (Gelman Sciences) and ad-
justed to 50 mM Na2HPO4, 300 mM NaCl, pH 8.0 (equilibration
bu¡er). Filtered supernatant was loaded onto a column containing
15 ml of Ni-NTA resin (Qiagen), previously equilibrated with equili-
bration bu¡er. The column was washed ¢rst with 60 ml of equilibra-
tion bu¡er and then with 50 ml of wash bu¡er (50 mM Na2HPO4, 300
mM NaCl, 10% glycerol, pH 6.0). Elution was carried out ¢rst with a
linear 0^75 mM imidazole gradient and then with a multi-step gra-
dient of 75, 90, 500 mM imidazole in wash bu¡er at a £ow rate of
1 ml/min. The eluant was monitored at 280 nm and all fractions were
assayed by radial di¡usion assay as described [10].
2.7. Puri¢cation of secreted MTI2 and Cpre-MTI2 proteins
Supernatant from cell culture, recovered as described above, was
diluted 1:1 with 20 mM sodium citrate, pH 3.0 (equilibration bu¡er)
and loaded onto a HiTrap SP column (Pharmacia), previously equil-
ibrated with the same bu¡er, at a £ow rate of 1 ml/min. The column
was then washed with ¢ve volumes of equilibration bu¡er. The ad-
sorbed MTI2 protein was eluted either with a 0^1 M NaCl linear
gradient in equilibration bu¡er or with a 150, 350, 1000 mM NaCl
step gradient. Eluant was monitored at 280 nm. All the fractions were
analyzed as previously described.
2.8. BApNA and Z-Arg-Arg-pNA assay
A colorimetric assay with the trypsin substrates BApNA (Sigma) or
Z-Arg-Arg-pNA (Bachem) was used to titrate the trypsin inhibitor
activity of puri¢ed recombinant proteins. 150 Wl of incubation bu¡er
(100 mM Tris^HCl pH 8.0, 10 mM CaCl2) containing bovine L-tryp-
sin at known concentration (in our studies either 0.5 nM (with Z-Arg-
Arg-pNA as substrate) or 35 nM (with BApNA as substrate)) and a
serial dilution of puri¢ed proteins was incubated at room temperature
for 30 min. The active concentration of bovine L-trypsin was previ-
ously titrated by the method of Chase and Shaw [11] using the titrant
p-nitrophenyl guanidinobenzoate. The residual trypsin activity was
measured by following the hydrolysis of the two substrates at 37‡C.
50 Wl of substrate bu¡er (100 mM Tris^HCl pH 8.0, 40% DMSO,
4 mM BApNA or 100 mM Tris^HCl pH 8.0, 10 mM CaCl2, 0.1 mg/
ml BSA, 1.5 mM Z-Arg-Arg-pNA) was added and the adsorbance of
the hydrolysis product p-nitroaniline [12] was measured at 405 nm.
2.9. Activity towards Spodoptera exigua gut proteases
Protease inhibitor activity of the puri¢ed recombinant MTI2 pro-
teins toward S. exigua gut proteases was determined with BApNA
according to Jongsma et al. [13]. S. exigua larvae were fed for
6 days on fresh tobacco leaves replaced every 12 h. Extraction of
guts was as described [13]. The potato proteinase inhibitor (PI2) pro-
tein [14] used in these assays was produced as a recombinant protein
in P. pastoris [15].
2.10. Tricine gel analysis
Tricine SDS^PAGE of proteins was according to Schagger and von
Jagow [16]. Activity PAGE was performed by a combination of the
activity PAGE procedure described in [8] for standard glycine gel and
the Tricine SDS^PAGE of proteins [16]. For activity PAGE, gelatin
to a ¢nal concentration of 0.1% was added to ‘spacer’ and ‘separating’
gels described in [16] and SDS omitted. Running and gel treatment
conditions were according to [8].
3. Results
3.1. Cloning of MTI2 sequences into the P. pastoris pPIC9
vector
The cDNA of the MTI2 gene for the whole mature protein
(EMBL accession number Y16190) (Fig. 1) was digested with
PstI and inserted into pUC19 SmaI-PstI sites. The resulting
plasmid was designated MTI2cDNA.
Di¡erent MTI2 constructs to be expressed in Pichia cells
were obtained by PCR ampli¢cations of the MTI2cDNA plas-
mid using the primer combinations 2/4, 3/5 and 3/4.
By cloning the 2/4 ampli¢cation fragment into the EcoRI
site of the P. pastoris pPIC9 secretory vector a 6UHis-tagged
mature MTI2 protein (His-MTI2) was produced. An addi-
tional four amino acids (Tyr-Val-Glu-Phe) are expected to
be present on the N-terminus of the protein secreted into
the medium (see Pichia Expression kit manual).
The expression of the 3/5 ampli¢cation fragment allowed
the production of the MTI2 protein bearing the last six amino
acids of the precursor polypeptide (Cpre-MTI2).
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Expression of the 3/4 ampli¢cation fragment resulted in the
production of the mature MTI2 (MTI2).
3.2. Screening of P. pastoris transformants
His clones showing the highest expression levels were se-
lected by radial di¡usion assay [10]. For every transformation,
minicultures of 70 His clones were grown and methanol
induced in 24 well tissue culture plates. After staining, more
than 70% of the colonies for the three di¡erent constructs
showed inhibitor activity, with levels of expression varying
up to four-fold as measured by colorless halo diameters (not
shown).
Clones showing trypsin inhibitor activity were also tested by
SDS^PAGE. In every instance a thick band of about 7 kDa,
which was absent from clones with no activity, was detectable
by silver staining (not shown).
3.3. Puri¢cation and characterization of His-MTI2
A 500 ml culture of a speci¢c clone selected for the highest
expression of the His-MTI2 recombinant protein was grown
for 96 h. The concentration of active recombinant protein in
the supernatant, determined by the BApNA assay, reached 40
mg/l. Puri¢cation of His-MTI2 was performed by a⁄nity
chromatography on a Ni-NTA column. The inhibitor activity,
revealed by radial di¡usion assay, was detectable in fractions
eluted by 90 mM imidazole (results not shown). The yield
of puri¢ed recombinant active protein was estimated to be
11 mg/l.
The apparent dissociation equilibrium constant (Ki) for the
recombinant protein and bovine L-trypsin as determined from
titration curves with a known amount of protease using the
equilibrium method [17] was found to be 0.71 nM (Table 1).
Fig. 1. Sequence of MTI2 gene cDNA fragment isolated by RT-
PCR. Amino acids deduced from the cDNA sequence are given in
the single letter code. Sequences corresponding to portions of oligo-
nucleotides used as PCR primers are underlined. Arrowheads indi-
cate 5P side of the corresponding oligonucleotide and its orientation.
Numbers on black background indicate oligonucleotide termini.
Complete oligonucleotide sequences are in Section 2. An asterisk in-
dicates the ¢rst and last amino acids of the mature protein.
Table 1
Ki for MTI2 proteins when tested with bovine L-trypsin
Inhibitor Ki (nM)
MTI2 (native) 0.16 [3]
MTI2 0.010 þ 0.002
Cpre-MTI2 0.58 þ 0.06
His-MTI2 0.71 þ 0.09
Values are from at least three separate determinations.
Fig. 2. PAGE analysis of the recombinant MTI2 protein. 0.8 Wg
from the supernatant of the Pichia culture (A) and 0.6 Wg from the
chromatographic fractions showing the highest trypsin inhibitor ac-
tivity (B) were electrophoresed through a Tricine SDS^16.5% poly-
acrylamide gel. Trypsin inhibitors were detected by activity gel: 0.05
Wg from the same sources as above was electrophoresed through a
Tricine gelatin^16.5% polyacrylamide gel. After electrophoresis, the
gel was incubated in a trypsin-containing solution to degrade gela-
tin. Bands of undegraded blue-stained gelatin indicate the presence
of trypsin inhibitors (AP and BP). The patterns shown for proteins
(A and B) and activities (AP and BP) correspond to the ‘separating’
phase of the gels. In all the ‘spacer’ phases neither proteins nor ac-
tivity could be detected.
Fig. 3. Titration of the trypsin inhibitor activity of recombinant
MTI2. 0.5 nM trypsin was incubated with increasing concentrations
of puri¢ed recombinant protein. The equilibrium dissociation con-
stant for the inhibitor was determined from this titration curve. The
residual trypsin activity was measured by Z-Phe-Arg-pNA hydroly-
sis.
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3.4. Puri¢cation and characterization of Cpre-MTI2 and MTI2
P. pastoris cultures for two highly expressing Cpre-MTI2
and MTI2 clones were grown and methanol induced as de-
scribed for the His-MTI2 culture. The concentration of active
recombinant MTI2 proteins in the supernatants reached 160
mg/l for Cpre-MTI2 and 70 mg/l for MTI2.
The recombinant proteins were puri¢ed from fermentation
media by ion exchange chromatography. Radial di¡usion as-
say allowed the identi¢cation of positive fractions in the range
300^450 mM NaCl for the linear gradient elution and at 350
mM NaCl for the step gradient elution.
In Fig. 2 gel electrophoresis of the recombinant MTI2 pro-
tein before and after chromatography is shown. Identi¢cation
of proteins with trypsin inhibitor activity on activity gels is
also shown (Fig. 2AP,BP).
The amount of puri¢ed active recombinant protein recov-
ered from ion exchange chromatography was estimated to be
120 mg for Cpre-MTI2, and 40 mg for MTI2 for 1 l of super-
natant from P. pastoris culture.
The apparent equilibrium dissociation constants of the two
recombinant proteins for bovine L-trypsin were found to di¡er
strongly. The mature protein had a Ki of 0.01 nM, while the
presence of six amino acids on the C-terminus reduced the Ki
58-fold (Table 1). Fig. 3 shows the titration curve obtained in
the case of the recombinant MTI2 protein.
The activity of recombinant Cpre-MTI2 and MTI2 was also
tested against proteases from S. exigua guts and compared to
the potato trypsin/chymotrypsin inhibitor II (PI2) [14]. S. ex-
igua is a widespread and polyphagous lepidopteran pest af-
fecting numerous crops [18]. Table 2 reports the residual pro-
tease activity present in S. exigua gut extracts after incubation
with an excess quantity (100 pmol) of the recombinant pro-
teins Cpre-MTI2, MTI2 and PI2. The combination of MTI2
(or Cpre-MTI2) with PI2 is only as e¡ective as a single inhib-
itor, indicating that the activity spectrum of the two inhibitor
types towards S. exigua trypsin-like proteases is similar. Re-
combinant MTI2 inhibitors appear to be marginally more
e¡ective, though, as inhibitors of trypsin-like proteases in
this insect.
4. Discussion
In this study we describe the expression in the yeast P.
pastoris of the mustard trypsin inhibitor MTI2, its C-terminal
precursor and a His-tagged form, together with their charac-
terization.
A previous attempt to express MTI2 in a prokaryotic sys-
tem was partially unsuccessful [19]. The MTI2 was expressed
as a fused protein with glutathione S-transferase (GST) but at
very low yield (0.1 mg/l), most likely as a consequence of the
high number of disul¢de bonds necessary for the proper fold-
ing of the protein.
To improve the expression level of recombinant MTI2 and
to facilitate its puri¢cation, P. pastoris cells were transformed
with the secretory expression vector pPIC9 containing the
cDNA for the MTI2 protein.
The His-MTI2 construct produced the recombinant protein
at about 40 mg/l of cell culture. Puri¢cation of this fraction by
a⁄nity chromatography on Ni-NTA resin gave a low yield
that was never higher than 25% of the active protein present
in the culture supernatant. The remaining protein probably
remained tightly bound to the resin, since it was not found
either in the £ow-through or in fractions eluted with bu¡er
containing higher concentrations of NaCl.
With the two constructs Cpre-MTI2 and MTI2, higher lev-
els of protein were obtained in the cultures: 160 mg/l and 70
mg/l, respectively. The di¡erences in the production of the
three proteins are probably accidental rather than a result
of the speci¢city or protein sequence of the proteins.
MTI2 proteins produced by Cpre-MTI2 and MTI2 strains
were further puri¢ed by ion exchange chromatography with
satisfactory yields ranging from 60 to 75%.
All three recombinant MTI2 proteins were active toward
bovine L-trypsin suggesting that each was properly folded
after expression and secretion from Pichia cells. The dissoci-
ation equilibrium constant of the His-MTI2 molecule was
higher than that reported for the mature protein, probably
due to the extra N-terminal amino acids present in the pro-
tein. The fact that the C-terminal precursor is about 60 times
less active than the mature protein could indicate a physio-
logical role for the C-terminal peptide in regulating the inhib-
itor activity towards endogenous proteases of mustard during
sequestration. Under our experimental conditions the re-
combinant mature MTI2 is 16 times more active than the
native protein puri¢ed from seeds [3] (Table 1). The di¡erence
between the constants measured for native and recombinant
mature MTI2 may be the result of di¡erences in the protein
sources.
Previous work established the potential defensive role of
MTI2 in plant defense against insects [8]. The recombinant
proteins were, therefore, also assayed toward trypsin-like ac-
tivities present in S. exigua gut extracts. Under the conditions
of the assay reported in Table 2, recombinant MTI2 proteins
showed a strong inhibitory activity similar to that of the po-
tato protease inhibitor PI2 [13]. The spectrum of activity of
the two inhibitors appears to be similar, because their combi-
nation did not increase the level of inhibition. The presence of
the C-terminal peptide did not appear to in£uence the level of
inhibition of the trypsin-like gut proteases at the concentra-
tions tested (Table 2). His-MTI2 was not used in the inhibi-
tion assays of S. exigua gut enzymes owing to its low activity
compared to the other MTI2 inhibitors.
The purity level of the MTI2 recombinant protein, as de-
tectable by SDS and activity gels, allows the use of the present
material for the formulation of arti¢cial diets in order to assay
MTI2 insecticide activity towards a wide range of di¡erent
phytophagous insects.
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